Merck & Co Inc
Change company Symbol lookup
Select an option...
MRK Merck & Co Inc
MSSAU Metal Sky Star Acquisition Corp
SDGR Schrodinger Inc
GPC Genuine Parts Co
VENA Venus Acquisition Corp
VECO Veeco Instruments Inc
IGTAU Inception Growth Acquisition Ltd
BAC-K Bank of America Corp
FAX abrdn Asia-Pacific Income Fund Inc
HIIIU Hudson Executive Investment Corp III
Go

Health Care : Pharmaceuticals | Large Cap Blend
Company profile

Merck & Co., Inc. is a global health care company. The Company offers health solutions through its prescription medicines, vaccines, biologic therapies and animal health products. It operates through two segments: Pharmaceutical and Animal Health. The Company's Pharmaceutical segment includes human health pharmaceutical and vaccine products. Its human health pharmaceutical products consist of therapeutic and preventive agents, generally sold by prescription, for the treatment of human disorders. The Company sells these human health pharmaceutical products primarily to drug wholesalers and retailers, hospitals, government agencies and managed health care providers such as health maintenance organizations. The Animal Health segment develops, manufactures and markets a range of veterinary pharmaceutical and vaccine products, as well as health management solutions and services, for the prevention, treatment and control of disease in all livestock and companion animal species.

Closing Price
$86.78
Day's Change
-0.73 (-0.83%)
Bid
--
Ask
--
B/A Size
--
Day's High
88.01
Day's Low
86.09
Volume
(Average)
Volume:
9,038,536

10-day average volume:
8,683,029
9,038,536

Display:

Providers:

UpdateCancel
4 providers
Yesterday's News, September 23, 2022
Merck & Co. Inc. Stock Outperforms Market Despite Losses On The Day

This article was automatically generated by MarketWatch using technology from Automated Insights. Shares of Merck & Co. Inc. (MRK) shed 0.83% to $86.78 Friday, on what proved to be an all-around dismal trading session for the stock...(MarketWatch)

September 22, 2022
Merck & Co. Inc. Stock Rises Thursday, Outperforms Market

This article was automatically generated by MarketWatch using technology from Automated Insights. Shares of Merck & Co. Inc. (MRK) advanced 3.53% to $87.51 Thursday, on what proved to be an all-around dismal trading session for the...(MarketWatch)

September 21, 2022
Merck & Co. Inc. Stock Falls Wednesday, Still Outperforms Market

This article was automatically generated by MarketWatch using technology from Automated Insights. Shares of Merck & Co. Inc. (MRK) slipped 1.71% to $84.53 Wednesday, on what proved to be an all-around grim trading session for the stock...(MarketWatch)

September 20, 2022
Merck & Co. Inc. Stock Outperforms Competitors Despite Losses On The Day

This article was automatically generated by MarketWatch using technology from Automated Insights. Shares of Merck & Co. Inc. (MRK) shed 0.74% to $86.00 Tuesday, on what proved to be an all-around dismal trading session for the stock...(MarketWatch)

Merck launches new Phase 3 trial of once-daily HIV treatment, to discontinue trial of once-monthly dose

Merck said Tuesday it is launching a new Phase 3 trial of once-daily islatravir for the treatment of people with HIV-1 infection. "These new Phase 3 studies will evaluate a once-daily oral combination of doravirine 100 mg and a lower dose of...(MarketWatch)

Merck to launch Phase 3 trial of once-daily islatravir for treatment of HIV-1 infection

(END) Dow Jones Newswires September 20, 2022 06:52 ET (10:52 GMT) (MarketWatch)

Merck to discontinue development of once-monthly oral Islatravir for PrEP

(END) Dow Jones Newswires September 20, 2022 06:50 ET (10:50 GMT) (MarketWatch)

September 19, 2022
Merck & Co. Inc. Stock Falls Monday, Underperforms Market

This article was automatically generated by MarketWatch using technology from Automated Insights. Shares of Merck & Co. Inc. (MRK) slipped 1.23% to $86.64 Monday, on what proved to be an all-around great trading session for the stock...(MarketWatch)

September 16, 2022
Merck & Co. Inc. Stock Rises Friday, Outperforms Market

This article was automatically generated by MarketWatch using technology from Automated Insights. Shares of Merck & Co. Inc. (MRK) rallied 1.12% to $87.72 Friday, on what proved to be an all-around poor trading session for the stock...(MarketWatch)

September 15, 2022
Merck & Co. Inc. Stock Underperforms Thursday When Compared To Competitors

This article was automatically generated by MarketWatch using technology from Automated Insights. Shares of Merck & Co. Inc. (MRK) slid 0.23% to $86.75 Thursday, on what proved to be an all-around grim trading session for the stock...(MarketWatch)

September 14, 2022
Merck & Co. Inc. Stock Underperforms Wednesday When Compared To Competitors Despite Daily Gains

This article was automatically generated by MarketWatch using technology from Automated Insights. Shares of Merck & Co. Inc. (MRK) advanced 1.59% to $86.95 Wednesday, on what proved to be an all-around favorable trading session for the...(MarketWatch)

September 13, 2022
Merck & Co. Inc. Stock Outperforms Competitors Despite Losses On The Day

This article was automatically generated by MarketWatch using technology from Automated Insights. Shares of Merck & Co. Inc. (MRK) shed 2.13% to $86.28 Tuesday, on what proved to be an all-around poor trading session for the stock...(MarketWatch)

September 12, 2022
Merck & Co. Inc. Stock Rises Monday, Still Underperforms Market

This article was automatically generated by MarketWatch using technology from Automated Insights. Shares of Merck & Co. Inc. (MRK) inched 0.94% higher to $88.16 Monday, on what proved to be an all-around favorable trading session for...(MarketWatch)

September 09, 2022
Merck & Co. Inc. Stock Falls Friday, Underperforms Market

This article was automatically generated by MarketWatch using technology from Automated Insights. Shares of Merck & Co. Inc. (MRK) dropped 0.09% to $87.34 Friday, on what proved to be an all-around positive trading session for the...(MarketWatch)

September 08, 2022
Merck & Co. Inc. Stock Rises Thursday, Still Underperforms Market

This article was automatically generated by MarketWatch using technology from Automated Insights. Shares of Merck & Co. Inc. (MRK) inched 0.63% higher to $87.42 Thursday, on what proved to be an all-around great trading session for the...(MarketWatch)

September 07, 2022
Merck & Co. Inc. Stock Rises Wednesday, Still Underperforms Market

This article was automatically generated by MarketWatch using technology from Automated Insights. Shares of Merck & Co. Inc. (MRK) inched 0.52% higher to $86.87 Wednesday, on what proved to be an all-around favorable trading session...(MarketWatch)

September 06, 2022
Merck & Co. Inc. Stock Outperforms Market On Strong Trading Day

This article was automatically generated by MarketWatch using technology from Automated Insights. Shares of Merck & Co. Inc. (MRK) inched 0.22% higher to $86.42 Tuesday, on what proved to be an all-around rough trading session for the...(MarketWatch)

September 02, 2022
Merck & Co. Inc. Stock Outperforms Competitors Despite Losses On The Day

This article was automatically generated by MarketWatch using technology from Automated Insights. Shares of Merck & Co. Inc. (MRK) slipped 1.06% to $86.23 Friday, on what proved to be an all-around dismal trading session for the stock...(MarketWatch)

September 01, 2022
Merck & Co. Inc. Stock Underperforms Thursday When Compared To Competitors Despite Daily Gains

This article was automatically generated by MarketWatch using technology from Automated Insights. Shares of Merck & Co. Inc. (MRK) rose 2.10% to $87.15 Thursday, on what proved to be an all-around favorable trading session for the...(MarketWatch)

August 31, 2022
Merck & Co. Inc. Stock Falls Wednesday, Underperforms Market

This article was automatically generated by MarketWatch using technology from Automated Insights. Shares of Merck & Co. Inc. (MRK) slipped 1.75% to $85.36 Wednesday, on what proved to be an all-around dismal trading session for the...(MarketWatch)

Next >

Earnings Calendar and Events Data provided by |Terms of Use| © 2022 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2022. All rights reserved.